PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Amortizatization of Intangibles (2024 - 2026)

PepGen (PEPG) posted Amortizatization of Intangibles of $822000.0 for Q1 2026, up 18.1% sequentially from $696000.0 in Q1 2025, and up 18.1% YoY from $696000.0 in Q1 2025.

Analysis

PepGen (PEPG) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends

PepGen has reported Amortizatization of Intangibles for 3 years, with the latest figure at $822000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles rose 18.1% year-over-year to $822000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (changed N/A YoY) and the FY2025 annual result came in at $2.2 million, down 43.64% from the prior year.
  • Amortizatization of Intangibles improved to $822000.0 in Q1 2026 per PEPG's latest filing, from $696000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $1.0 million in Q4 2024 and troughed at $516000.0 in Q1 2024.
  • A 3-year average of $763500.0 and a median of $759000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles surged 34.88% in 2025, then advanced 18.1% in 2026.
  • Over 3 years, Amortizatization of Intangibles stood at $1.0 million in 2024, then slumped by 31.76% to $696000.0 in 2025, then rose by 18.1% to $822000.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $822000.0, $696000.0, and $1.0 million for Q1 2026, Q1 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 PepGen 217.99 Mn 217.99 Mn - 892,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 892,000.00
Mar 31, 2026 822,000.00
Jun 30, 2025 454,000.00
Mar 31, 2025 696,000.00
Dec 31, 2024 1.02 Mn
Mar 31, 2024 516,000.00